Phase II trial to assess safety and efficacy of Iron chelating agent Deferiprone in patients with Pantothenate Kinase-Associated Neurodegeneration ? ICAND ? Trial - ND Phase II trial to assess safety and efficacy of Iron chelating agent Deferiprone in patients with Pa ...
Phase II trial to assess safety and efficacy of Iron chelating agent Deferiprone in patients with Pantothenate Kinase-Associated Neurodegeneration ? ICAND ? Trial - ND Phase II trial to assess safety and efficacy of Iron chelating agent Deferiprone in patients with Pa ...